Safety, efficacy and immune effects of venetoclax 400 mg daily in patients with relapsed chronic lymphocytic leukemia (CLL) Meeting Abstract
| Authors: | Davids, M. S.; Roberts, A. W.; Seymour, J. F.; Gerecitano, J. F.; Kahl, B. S.; Kipps, T. J.; Pagel, J. M.; Puvvada, S. D.; Gressick, L. A.; Zhu, M.; Dunbar, M.; Chyla, B.; Verdugo, M. E.; Kim, S. Y.; Wierda, W. G. |
| Abstract Title: | Safety, efficacy and immune effects of venetoclax 400 mg daily in patients with relapsed chronic lymphocytic leukemia (CLL) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 401s |
| Language: | English |
| ACCESSION: | WOS:000404711505040 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.7527 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7527 -- Source: Wos |
